ABANZA
Hugo Domínguez, Partner & CCO
Juan Abascal, CEO & Co-Founder

ABANZA has developed a disruptive new platform for arthroscopic soft tissue fixation.

The first products launched—the FDA-cleared WasherCap™ and WasherCap™ Mini—provide stronger and more rigid fixation for soft tissue grafts and sutures/tapes used in ACL reconstruction, meniscal root repair, and TFCC procedures. These implants feature unique mechanical properties and the ability to re-tension the fixation at any point during surgery.

While initial indications have focused on the knee, ABANZA is now expanding its platform with new fixation devices for additional anatomical areas, including foot and ankle, biceps tenodesis, hand and wrist, hip, and shoulder.

With a growing portfolio of surgical solutions, ABANZA aims to become a leading reference in soft tissue and sports medicine repair procedures, ushering in A New Era in Soft Tissue Fixation

abanzamed.com